Table 1.
Patients profiles
| Patient no. | Age | Contents (p.f.u) X Time | Injection site | Staginga (radiological) | Staginga (postoperative) | |
|---|---|---|---|---|---|---|
| Cohort 1 | HF-1-02 | 60s | 1X106X4 | Pancreas head | III (T4N0M0) | NA |
| HF-1-04 | 60s | 1X106X4 | Pancreas head (uncinate process) | III (T4N0M0) | NA | |
| HF-1-05 | 60s | 1X106X4 | Pancreas body | III (T4N0M0) | IIA (T3N0M0) | |
| Cohort 2 | HF-2-01 | 60s | 3X106X4 | Pancreas body | III (T4N0M0) | NA |
| HF-2-02 | 60s | 3X106X4 | Pancreas head (uncinate process) | III (T4N0M0) | IIA (T3N0M0) | |
| HF-2-03 | 60s | 3X106X4 | Pancreas body | III (T4N0M0) | NA | |
| Cohort 3 | HF-3-01 | 60s | 1X107X3 | Pancreas body | III (T4N0M0) | NA |
| HF-3-02 | 50s | 1X107X4 | Pancreas head (uncinate process) | III (T4N0M0) | NA | |
| HF-3-03 | 60s | 1X107X4 | Pancreas body | III (T4N0M0) | NA | |
| HF-3-04 | 60s | 1X107X4 | Pancreas head | III (T4N0M0) | NA | |
aBased on NCCN Clinical Practice Guidelines in Oncology [13]